This could explain why KP levels and in extension kynurenine-related neuroinflammation might be lower in our ALS patients, since aging is a primary risk factor for neuroinflammation, as well as neurodegenerative diseases in general [49]. This evidence concerns the gene NPPA and neurodegenerative disease.